These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 19157721)
1. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721 [TBL] [Abstract][Full Text] [Related]
2. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187 [TBL] [Abstract][Full Text] [Related]
3. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765 [TBL] [Abstract][Full Text] [Related]
4. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840 [TBL] [Abstract][Full Text] [Related]
5. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987 [TBL] [Abstract][Full Text] [Related]
7. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307 [TBL] [Abstract][Full Text] [Related]
8. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors. Gates VL; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Nemcek AA; Omary R; Salem R Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504 [TBL] [Abstract][Full Text] [Related]
9. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary? McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592 [TBL] [Abstract][Full Text] [Related]
10. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558 [TBL] [Abstract][Full Text] [Related]
12. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Welsh JS; Kennedy AS; Thomadsen B Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443 [TBL] [Abstract][Full Text] [Related]
13. State of the art: radiolabeled microspheres treatment for liver malignancies. Deleporte A; Flamen P; Hendlisz A Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269 [TBL] [Abstract][Full Text] [Related]
14. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997 [TBL] [Abstract][Full Text] [Related]
15. Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres. Sangro B; Bilbao JI; Iñarrairaegui M; Rodriguez M; Garrastachu P; Martinez-Cuesta A Dig Dis; 2009; 27(2):164-9. PubMed ID: 19546555 [TBL] [Abstract][Full Text] [Related]
16. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920 [TBL] [Abstract][Full Text] [Related]
17. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181 [TBL] [Abstract][Full Text] [Related]
18. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors. Neff R; Abdel-Misih R; Khatri J; Dignazio M; Garcia M; Petrelli N; Wilson P Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948 [TBL] [Abstract][Full Text] [Related]
19. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231 [TBL] [Abstract][Full Text] [Related]
20. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]